Suppr超能文献

重新思考我们如何在实施研究中衡量成本。

Rethinking How We Measure Costs in Implementation Research.

机构信息

VA Health Economics Resource Center, 795 Willow Rd., 152-MPD, Menlo Park, CA, 94025, USA.

Stanford-Surgery Policy Improvement Research and Education Center, Department of Surgery, Stanford School of Medicine , Stanford, CA, USA.

出版信息

J Gen Intern Med. 2020 Nov;35(Suppl 2):870-874. doi: 10.1007/s11606-020-06104-6. Epub 2020 Oct 26.

Abstract

BACKGROUND

Hospitals and other health care delivery organizations are sometimes resistant to implementing evidence-based programs, citing unknown budgetary implications.

OBJECTIVE

In this paper, I discuss challenges when estimating health care costs in implementation research.

DESIGN

A case study with intensive care units highlights how including fixed costs can cloud a short-term analysis.

PARTICIPANTS

None.

INTERVENTIONS

None.

MAIN MEASURES

Health care costs, charges and payments.

KEY RESULTS

Cost data should accurately reflect the opportunity costs for the organization(s) providing care. Opportunity costs are defined as the benefits foregone because the resources were not used in the next best alternative. Because there is no database of opportunity costs, cost studies rely on accounting data, charges, or payments as proxies. Unfortunately, these proxies may not reflect the organization's opportunity costs, especially if the goal is to understand the budgetary impact in the next few years.

CONCLUSIONS

Implementation researchers should exclude costs that are fixed in the time period of observation because these assets (e.g., space) cannot be used in the next best alternative. In addition, it is common to use costs from accounting databases where we implicitly assume health care providers are uniformly efficient. If providers are not operating efficiently, especially if there is variation in their efficiency, then this can create further problems. Implementation scientists should be judicious in their use of cost estimates from accounting data, otherwise research results can misguide decision makers.

摘要

背景

医院和其他医疗保健提供组织有时对实施基于证据的项目持抵制态度,理由是未知的预算影响。

目的

本文讨论了在实施研究中估计医疗保健成本时所面临的挑战。

设计

以重症监护病房为例,说明了包含固定成本如何使短期分析变得复杂。

参与者

无。

干预措施

无。

主要措施

医疗保健成本、收费和支付。

主要结果

成本数据应准确反映提供护理的组织的机会成本。机会成本是指由于资源未用于下一个最佳替代方案而放弃的收益。由于没有机会成本数据库,成本研究依赖于会计数据、收费或支付作为替代物。不幸的是,这些替代物可能无法反映组织的机会成本,特别是如果目标是了解未来几年的预算影响。

结论

实施研究人员应排除在观察期内固定的成本,因为这些资产(例如空间)无法在下一个最佳替代方案中使用。此外,在使用会计数据库中的成本时,我们通常会默认医疗保健提供者具有统一的效率。如果提供者的效率不高,特别是如果他们的效率存在差异,那么这可能会带来进一步的问题。实施科学家应谨慎使用来自会计数据的成本估算,否则研究结果可能会误导决策者。

相似文献

1
Rethinking How We Measure Costs in Implementation Research.重新思考我们如何在实施研究中衡量成本。
J Gen Intern Med. 2020 Nov;35(Suppl 2):870-874. doi: 10.1007/s11606-020-06104-6. Epub 2020 Oct 26.
5
Estimating Downstream Budget Impacts in Implementation Research.估算实施研究中的下游预算影响。
Med Decis Making. 2020 Nov;40(8):968-977. doi: 10.1177/0272989X20954387. Epub 2020 Sep 19.
6
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
9
How to develop cost-conscious guidelines.如何制定注重成本的指南。
Health Technol Assess. 2001;5(16):1-69. doi: 10.3310/hta5160.

引用本文的文献

8
The economics of adaptations to evidence-based practices.基于证据的实践的适应经济学。
Implement Sci Commun. 2022 Sep 24;3(1):100. doi: 10.1186/s43058-022-00345-8.

本文引用的文献

6
Breaking the addiction to technology adoption.戒除技术采用成瘾。
Health Econ. 2014 Apr;23(4):379-83. doi: 10.1002/hec.3034.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验